Edition:
United States

Biocept Inc (BIOC.OQ)

BIOC.OQ on NASDAQ Stock Exchange Capital Market

0.70USD
12:06pm EST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$0.70
Open
$0.71
Day's High
$0.71
Day's Low
$0.69
Volume
17,764
Avg. Vol
86,141
52-wk High
$3.38
52-wk Low
$0.60

Latest Key Developments (Source: Significant Developments)

Sabby Management LLC Reports A 9.20 Pct Passive Stake In Biocept
Wednesday, 6 Dec 2017 01:16pm EST 

Dec 6 (Reuters) - Biocept Inc ::SABBY MANAGEMENT LLC REPORTS A 9.20 PCT PASSIVE STAKE IN BIOCEPT INC <<>> AS OF DEC 5 - SEC FILING.  Full Article

Biocept announces pricing of public offering of up to 4,925,936 shares of common stock
Wednesday, 6 Dec 2017 08:05am EST 

Dec 6 (Reuters) - Biocept Inc ::BIOCEPT ANNOUNCES PRICING OF PUBLIC OFFERING OF UP TO 4,925,936 SHARES OF COMMON STOCK.BIOCEPT - ‍PRICED BEST EFFORTS REGISTERED PUBLIC OFFERING OF UP TO 4.9 MILLION SHARES OF CO'S COMMON STOCK AT PRICE TO PUBLIC OF $0.68/SHARE​.  Full Article

Biocept files for offering $10 mln of shares of co's common stock and warrants
Friday, 17 Nov 2017 04:32pm EST 

Nov 17 (Reuters) - Biocept Inc :Biocept Inc files for offering $10 million of shares of co's common stock and warrants - SEC Filing.Biocept - shares of co's common stock and warrants are immediately separable and will be issued separately, but will be purchased together in the offering.  Full Article

Biocept reports Q3 loss per share $0.20
Thursday, 9 Nov 2017 04:05pm EST 

Nov 9 (Reuters) - Biocept Inc :Biocept reports third quarter 2017 financial results.Q3 loss per share $0.20.Q3 revenue rose 6 percent to $1.1 million.Biocept Inc - ‍cash and cash equivalents were $5.9 million as of September 30, 2017​.  Full Article

Biocept and Miraca Life Sciences enter into marketing agreement
Tuesday, 3 Oct 2017 08:05am EDT 

Oct 3 (Reuters) - Biocept Inc ::Biocept and Miraca Life Sciences enter into marketing agreement to expand target selector testing in the United States.Biocept Inc - ‍Biocept will perform all tests in its clia-certified laboratory in San Diego​.  Full Article

Biocept Inc files for disposition of up to 2.9 million shares of common stock
Friday, 18 Aug 2017 04:34pm EDT 

Aug 18 (Reuters) - Biocept Inc ::Biocept Inc files for disposition of up to 2.9 million shares of common stock by the selling stockholders.  Full Article

Biocept enters into distribution agreement with Global Laboratory Product Supplier VWR
Monday, 14 Aug 2017 08:05am EDT 

Aug 14 (Reuters) - Biocept Inc :Biocept enters into exclusive distribution agreement with Global Laboratory Product Supplier VWR.Biocept Inc - commercial launch is anticipated to begin in second half of 2017..  Full Article

Biocept Q2 loss per share $0.21
Thursday, 10 Aug 2017 04:05pm EDT 

Aug 10 (Reuters) - Biocept Inc :Says ‍revenues for Q2 of 2017 increased 93% to $1.3 million​.Biocept reports second quarter 2017 financial results.Q2 loss per share $0.21.Q2 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S.Q2 revenue view $1.3 million -- Thomson Reuters I/B/E/S.  Full Article

Biocept announces private placement of $2.2 mln of common stock
Thursday, 10 Aug 2017 08:05am EDT 

Aug 10 (Reuters) - Biocept Inc :Biocept announces private placement of $2.2 million of common stock with Ally Bridge LB Healthcare Master Fund.Private placement of $2.2 million of common stock with Ally Bridge LB Healthcare Master Fund at a offering price of $1.50​.Co, Ally Bridge's Chinese affiliate in discussions to evaluate potential strategic opportunities to leverage Biocept's liquid biopsy platform.  Full Article

Biocept launches liquid biopsy test for progesterone receptor detection
Friday, 14 Jul 2017 08:05am EDT 

July 14 (Reuters) - Biocept Inc ::Biocept expands commercial offering of clinically actionable biomarker assays with launch of liquid biopsy test for progesterone receptor detection.Biocept Inc - commercial availability of its new liquid biopsy test for progesterone receptor (PR).  Full Article

BRIEF-Sabby Management LLC Reports A 9.20 Pct Passive Stake In Biocept

* SABBY MANAGEMENT LLC REPORTS A 9.20 PCT PASSIVE STAKE IN BIOCEPT INC AS OF DEC 5 - SEC FILING Source text: (http://bit.ly/2ACbgue) Further company coverage: